ImmunityBio, Inc. - Common Stock —— 季度资产负债表 (NASDAQ:IBRX) | MetaTrader

展开完整图表完整图表

新闻

IBRX and the BCG Shortage: Deals That Could Expand Demand

IBRX Stock Outlook After Q1 Results and a New FDA Review

ImmunityBio: Anktiva Explained and What Comes Next

Undercovered Stocks: Cerebras Systems, Infleqtion, Duos Technologies And More

FDA Accepts IBRX's Filing Seeking Expanded Use of Bladder Cancer Therapy

ImmunityBio Secures Five U.S. Patents for Anktiva in Bladder Cancer

ImmunityBio: Looking Beyond Bladder Cancer To A Multibillion-Dollar Solid Tumor TAM (IBRX)

ImmunityBio (IBRX) Reports Q1 Loss, Tops Revenue Estimates

Why ImmunityBio Stock Is Surging On Wednesday? - ImmunityBio (NASDAQ:IBRX)

ImmunityBio to Report Q1 Earnings: What's in the Cards?

IBRX Global Rollout: EU, MENA, and Asia Shape 2026-27 Catalysts

Is IBRX Priced for Perfection at Nearly 28x Forward Sales?